Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours

Pharmaceuticals, Free Full-Text

Frontiers The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors

The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively - Li - 2021 - Cancer Medicine - Wiley Online Library

Vaccines, Free Full-Text

Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches, Journal of Nanobiotechnology

Unlocking the potential of antibody–drug conjugates for cancer therapy

Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors - ScienceDirect

Molecules, Free Full-Text

Histology-agnostic approvals for antibody–drug conjugates in solid tumours: is the time ripe? - ScienceDirect

Antibody–drug conjugate - Wikipedia

Antibody-drug Conjugate: A “Biological Missile” for Tumor Targeted Therapy – Creative Biolabs Blog

The ever-expanding landscape of antibody-drug conjugates (ADCs) in solid tumors: A systematic review - ScienceDirect